论文部分内容阅读
为了提高癌症病人费用-效益比,对肿瘤标志物测定与骨扫描结合的最佳方案进行了前瞻性研究。方法:选择1995年12月至1997年4月行骨扫描的病人,在检查当天采血测定相关的肿瘤标志物。其中,乳腺癌病人157例,检测血清CA15-3;肺癌病人118例,检测血清癌胚抗原(CEA)和细胞角蛋白片段21-
In order to improve the cost-benefit ratio of cancer patients, a prospective study was performed on the best combination of tumor marker determination and bone scan. METHODS: Patients who underwent bone scans between December 1995 and April 1997 were selected and blood tests were performed to determine the relevant tumor markers. Among them, 157 patients with breast cancer, serum CA15-3, 118 patients with lung cancer, serum CEA and cytokeratin fragments 21-